These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7576314)

  • 21. Molecular modulation of calcium oxalate crystallization.
    De Yoreo JJ; Qiu SR; Hoyer JR
    Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1123-31. PubMed ID: 17082348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simple classification of renal calculi closely related to their micromorphology and etiology.
    Grases F; Costa-Bauzá A; Ramis M; Montesinos V; Conte A
    Clin Chim Acta; 2002 Aug; 322(1-2):29-36. PubMed ID: 12104078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of biomolecules from human renal matrix of calcium oxalate monohydrate (CaOx) stones on in vitro calcium phosphate crystallization.
    Pathak P; Singh SK; Tandon C
    Int Braz J Urol; 2010; 36(5):621-8. PubMed ID: 21044380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal papillary calcification and the development of calcium oxalate monohydrate papillary renal calculi: a case series study.
    Grases F; Costa-Bauzá A; Prieto RM; Conte A; Servera A
    BMC Urol; 2013 Mar; 13():14. PubMed ID: 23497010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimated levels of supersaturation with calcium phosphate and calcium oxalate in the distal tubule.
    Tiselius HG
    Urol Res; 1997; 25(2):153-9. PubMed ID: 9144885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations in MDCK and LLC-PK1 cells exposed to oxalate and calcium oxalate monohydrate crystals.
    Hackett RL; Shevock PN; Khan SR
    Scanning Microsc; 1995 Jun; 9(2):587-96. PubMed ID: 8714751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of crystal surface adhesion in kidney stone disease.
    Wesson JA; Ward MD
    Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):386-93. PubMed ID: 16775453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors affecting the regrowth of renal stones in vitro: a contribution to the understanding of renal stone development.
    Costa-Bauzá A; Isern B; Perelló J; Sanchis P; Grases F
    Scand J Urol Nephrol; 2005; 39(3):194-9. PubMed ID: 16118089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formation of hydrated calcium oxalates in the presence of poly-L-aspartic acid.
    Wesson JA; Worcester E
    Scanning Microsc; 1996; 10(2):415-23; 423-4. PubMed ID: 9813620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased calcium oxalate crystal nucleation and aggregation by peroxidized protein of human kidney stone matrix and renal cells.
    Govindaraj A; Selvam R
    Urol Res; 2001 Jun; 29(3):194-8. PubMed ID: 11482446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxalate binding proteins in calcium oxalate nephrolithiasis.
    Selvam R; Kalaiselvi P
    Urol Res; 2003 Aug; 31(4):242-56. PubMed ID: 12856168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of hypercalcic and/or hyperoxalic diet on calcium oxalate renal stone formation in rats.
    Bardouri M; Neffati F; Trimeche M; Elhani A; Fadhel Najjar M; Sakly R
    Scand J Urol Nephrol; 2006; 40(3):187-91. PubMed ID: 16809257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental technique simulating oxalocalcic renal stone generation.
    Söhnel O; Grases F; March JG
    Urol Res; 1993 Mar; 21(2):95-9. PubMed ID: 8503154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The osteopontin-controlled switching of calcium oxalate monohydrate morphologies in artificial urine provides insights into the formation of papillary kidney stones.
    Langdon A; Grohe B
    Colloids Surf B Biointerfaces; 2016 Oct; 146():296-306. PubMed ID: 27362921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physical chemical studies of calcium oxalate crystallization.
    Nancollas GH; Smesko SA; Campbell AA; Richardson CF; Johnsson M; Iadiccico RA; Binette JP; Binette M
    Am J Kidney Dis; 1991 Apr; 17(4):392-5. PubMed ID: 2008905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The hole truth: intracrystalline proteins and calcium oxalate kidney stones.
    Ryall RL; Fleming DE; Grover PK; Chauvet M; Dean CJ; Marshall VR
    Mol Urol; 2000; 4(4):391-402. PubMed ID: 11156707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New aspects on the composition, structure and origin of calcium oxalate monohydrate calculi.
    Grases F; March JG; Conte A; Costa-Bauzá A
    Eur Urol; 1993; 24(3):381-6. PubMed ID: 8262107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular modifiers reveal a mechanism of pathological crystal growth inhibition.
    Chung J; Granja I; Taylor MG; Mpourmpakis G; Asplin JR; Rimer JD
    Nature; 2016 Aug; 536(7617):446-50. PubMed ID: 27501150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of a protein inhibitor isolated from human renal stone matrix in urolithiasis.
    Aggarwal S; Tandon C; Forouzandeh M; Singla SK; Kiran R; Jethi RK
    Indian J Biochem Biophys; 2005 Apr; 42(2):113-7. PubMed ID: 23923571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Papillary and cavitary monohydrate calcium oxalate lithiasis: comparative study of etiological factors].
    Pieras Ayala E; Grases Freixedas F; Costa Bauzá A; Ramis Barceló M; Pizá Reus P; Ozonas Moragues M
    Arch Esp Urol; 2006 Mar; 59(2):147-54. PubMed ID: 16649520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.